首页> 外文期刊>Endocrine journal >HMG-CoA Reductase Inhibitors (statins) might Cause High Elevations of Creatine Phosphokinase (CK) in Patients with Unnoticed Hypothyroidism
【24h】

HMG-CoA Reductase Inhibitors (statins) might Cause High Elevations of Creatine Phosphokinase (CK) in Patients with Unnoticed Hypothyroidism

机译:HMG-CoA还原酶抑制剂(他汀类药物)可能会导致甲状腺功能减退症患者的肌酸磷酸激酶(CK)升高

获取原文
           

摘要

References(22) Cited-By(19) Serious side effects of statins, including severe myopathy and rhabdomyolysis, are rare but important in general practice. Hypothyroidism can cause secondary hypercholesterolemia and myopathy. There have been few reports on the risk of statins in patient with unnoticed hypothyroidism. We analyzed the characteristics of 77 patients with primary hypothyroidism in our hospital. Nine patients (11%) accidentally received statins in the treatment of hypercholesterolemia without diagnosis of hypothyroidism. In such patients, free T4 (FT4) levels were lower, and those of LDH, CK were higher than those in patients not receiving statins. In patients accidentally receiving statins, an inverse correlation between CK and FT4 could not be shown (which was recognized in patients not receiving them). Even after FT4 levels were matched, levels of CK were still higher in the patients accidentally receiving statins. Patients with high CK levels over 1000 U/L were 5 times more frequent (56%) in patients accidentally receiving statins than in those not receiving statins (11%). The present study confirms that statins enhances levels of CK in patients with hypothyroidism. We must not begin and continue to use these drugs without checking the possibility of hypothyroidism.
机译:参考文献(22)被引用(19)他汀类药物的严重副作用(包括严重的肌病和横纹肌溶解)很少见,但在一般实践中很重要。甲状腺功能减退症可引起继发性高胆固醇血症和肌病。关于甲状腺功能减退症患者中他汀类药物风险的报道很少。我们分析了我院77例原发性甲状腺功能减退症患者的特征。九名患者(11%)在未诊断为甲状腺功能减退的情况下意外接受他汀类药物治疗高胆固醇血症。在这类患者中,游离T4(FT4)水平较低,而LDH,CK的游离T4(FT4)水平则高于未接受他汀类药物的患者。在意外接受他汀类药物的患者中,未显示出CK和FT4之间呈反相关关系(未接受他汀类药物的患者已认识到)。即使在FT4水平匹配之后,意外接受他汀类药物的患者的CK水平仍然更高。 CK水平超过1000 U / L的患者,意外接受他汀类药物的患者(56%)的频率是未接受他汀类药物的患者(11%)的5倍。本研究证实他汀类药物可提高甲状腺功能减退症患者的CK水平。在检查甲状腺功能减退的可能性之前,我们绝不能开始并继续使用这些药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号